所有标记为「diabetes」的文章
研究人员表示，在基因组的非编码区域中发现了婴儿糖尿病新的遗传致病原因，而以往研究常常忽略这些区域。
一项研究发现，2023年每月35美元限价生效后，医保患者在胰岛素上的支出减少，并有证据显示更多患者坚持了治疗。
Polymer nanoparticle startup BreezeBio has raised $60 million to advance an mRNA-based therapy for diabetes that uses novel delivery technology to target pancreatic cells. The approach could offer a fundamentally different treatment paradigm for the hundreds of millions living with the disease.
Silicon Valley startup Twin Health is using continuous sensor data and artificial intelligence to build virtual replicas of patients' metabolisms, creating personalized treatment plans that have helped thousands reduce medications and reverse type 2 diabetes symptoms.
A retrospective analysis of 174,000 patients finds tirzepatide users develop diabetic retinopathy at significantly lower rates than matched controls.
Large-scale study finds GLP-1 receptor agonists significantly reduce diabetic retinopathy risk and other eye complications in type 2 diabetes patients.
